Migraine: Epidemiology, Burden, and Comorbidity

Rebecca C. Burch, Dawn C. Buse, Richard B. Lipton

Research output: Contribution to journalReview article

4 Scopus citations

Abstract

Migraine affects an estimated 12% of the population. Global estimates are higher. Chronic migraine (CM) affects 1% to 2% of the global population. Approximately 2.5% of persons with episodic migraine progress to CM. Several risk factors are associated with the progression to CM. There is significant short-term variability in migraine frequency independent of treatment. Migraine is associated with cardiovascular disease, psychiatric disease, and sleep disorders. It is the second most disabling condition worldwide. CM is associated with higher headache-related disability/impact, medical and psychiatric comorbidities, health care resource use, direct and indirect costs, lower socioeconomic status, and health-related quality of life.

Original languageEnglish (US)
Pages (from-to)631-649
Number of pages19
JournalNeurologic Clinics
Volume37
Issue number4
DOIs
StatePublished - Nov 2019

    Fingerprint

Keywords

  • Chronic migraine (CM)
  • Comorbidity
  • Headache-related disability
  • Incidence
  • Migraine
  • Prevalence
  • Progression
  • Risk factors

ASJC Scopus subject areas

  • Clinical Neurology

Cite this